A first-in-man clinical trial of Micropump sodium oxybate in healthy volunteers

Trial Profile

A first-in-man clinical trial of Micropump sodium oxybate in healthy volunteers

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 03 Jan 2017

At a glance

  • Drugs Sodium oxybate (Primary)
  • Indications Narcolepsy
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 03 Jan 2017 This trial was planned by Flamel Technologies. The company has completed cross-border merger and became Avadel Pharmaceuticals plc, according to a Flamel Technologies media release.
    • 12 Jan 2016 Planned End Date changed to 1 Jun 2017.
    • 08 Jan 2016 According to Flamel Technologies media release, target for completing this trial remains mid-2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top